Weigao Group (1066.HK) repurchases shares on HKEX
Shandong Weigao Group Medical Polymer Company Limited (HKEX:1066) announced today that it repurchased 160,000 of its own shares on the Hong Kong Stock Exchange. The shares were bought at prices ranging from HKD5.77 to HKD5.90 per share, resulting in a total aggregate price paid of HKD938,000. The buyback was conducted under a mandate approved on May 27, 2025. Following this transaction, the total number of shares repurchased on the Exchange now stands at 1,280,400, representing 0.2836% of the issued shares as of the mandate date. The company is subject to a moratorium on issuing new shares or selling treasury shares until July 19, 2025.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
News Alerts
Get instant email alerts when Shandong Weigao Group publishes news
Free account required • Unsubscribe anytime